Current and historical daily PE Ratio for GlaxoSmithKline Consumer Nigeria PLC (
NSA:GLAXOSMITH
) from 2001 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GlaxoSmithKlinensumer Nigeria PLC stock (NSA:GLAXOSMITH) PE ratio as of Jun 10 2024 is 34.
More Details
GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) PE Ratio (TTM) Chart
GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) PE Ratio (TTM) Historical Data
View and export this data going back to 2001. Start your Free Trial
Total 1180
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| GlaxoSmithKlinensumer Nigeria PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 34.0 | 2023-12-06 | 34.0 |
| 2024-02-09 | 34.0 | 2023-12-05 | 34.0 |
| 2024-02-08 | 34.0 | 2023-12-04 | 33.1 |
| 2024-02-07 | 34.0 | 2023-12-01 | 33.1 |
| 2024-02-06 | 34.0 | 2023-11-30 | 33.1 |
| 2024-02-05 | 34.0 | 2023-11-29 | 32.2 |
| 2024-02-02 | 34.0 | 2023-11-28 | 32.2 |
| 2024-02-01 | 34.0 | 2023-11-27 | 33.7 |
| 2024-01-31 | 34.0 | 2023-11-24 | 33.4 |
| 2024-01-30 | 34.0 | 2023-11-23 | 33.4 |
| 2024-01-29 | 34.0 | 2023-11-22 | 33.4 |
| 2024-01-26 | 34.0 | 2023-11-21 | 33.3 |
| 2024-01-25 | 34.0 | 2023-11-20 | 33.0 |
| 2024-01-24 | 34.0 | 2023-11-17 | 33.0 |
| 2024-01-23 | 34.0 | 2023-11-16 | 32.2 |
| 2024-01-22 | 34.0 | 2023-11-15 | 32.4 |
| 2024-01-19 | 34.0 | 2023-11-14 | 32.4 |
| 2024-01-18 | 33.6 | 2023-11-13 | 32.1 |
| 2024-01-17 | 33.6 | 2023-11-10 | 32.1 |
| 2024-01-16 | 33.6 | 2023-11-09 | 32.1 |
| 2024-01-15 | 33.6 | 2023-11-08 | 31.4 |
| 2024-01-12 | 33.6 | 2023-11-07 | 29.9 |
| 2024-01-11 | 33.6 | 2023-11-06 | 27.2 |
| 2024-01-10 | 33.6 | 2023-11-03 | 24.8 |
| 2024-01-09 | 34.0 | 2023-11-02 | 24.0 |
| 2024-01-08 | 34.0 | 2023-11-01 | 24.0 |
| 2024-01-05 | 34.0 | 2023-10-31 | 24.4 |
| 2024-01-04 | 34.0 | 2023-10-30 | 24.4 |
| 2024-01-03 | 34.0 | 2023-10-27 | 24.4 |
| 2024-01-02 | 34.0 | 2023-10-26 | 24.6 |
| 2023-12-29 | 34.0 | 2023-10-25 | 24.6 |
| 2023-12-28 | 34.0 | 2023-10-24 | 24.6 |
| 2023-12-27 | 34.0 | 2023-10-23 | 24.6 |
| 2023-12-22 | 34.0 | 2023-10-20 | 24.6 |
| 2023-12-21 | 34.0 | 2023-10-19 | 24.6 |
| 2023-12-20 | 33.4 | 2023-10-18 | 24.3 |
| 2023-12-19 | 33.4 | 2023-10-17 | 24.3 |
| 2023-12-18 | 33.4 | 2023-10-16 | 24.3 |
| 2023-12-15 | 33.4 | 2023-10-13 | 24.3 |
| 2023-12-14 | 33.4 | 2023-10-12 | 22.6 |
| 2023-12-13 | 33.4 | 2023-10-11 | 22.6 |
| 2023-12-12 | 33.8 | 2023-10-10 | 22.6 |
| 2023-12-11 | 33.8 | 2023-10-09 | 22.6 |
| 2023-12-08 | 33.8 | 2023-10-06 | 22.8 |
| 2023-12-07 | 34.0 | 2023-10-05 | 25.0 |
GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
GlaxoSmithKline Consumer Nigeria PLC
ISIN : NGGLAXOSMTH8
Description
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers